Bariatric surgery is known to improve metabolic parameters and decrease the risk of NAFLD in individuals with severe obesity, which is largely attributed to the substantial weight loss, enhanced insulin sensitivity, and reduced inflammation following surgery [64]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.